(Q34058722)

30 July 2017

1 reference

title

Testosterone: a natural tonic for the failing heart? (English)

1 reference

30 July 2017

1 reference

1 reference

Pugh PJ

1

1 reference

30 July 2017

English KM

series ordinal

2

1 reference

30 July 2017

Jones TH

series ordinal

3

1 reference

30 July 2017

Channer KS

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

QJM: An International Journal of Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

93

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

689-694

1 reference

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Pituitary-gonadal dysfunction in low-output cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Testosterone and coronary heart disease: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Effect of testosterone cypionate on postexercise ST segment depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Acute anti-ischemic effect of testosterone in men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Androgen-induced enhancement of vascular reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Basic mechanisms in heart failure: the cytokine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Sex hormones modulate inflammatory mediators produced by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2F93.10.689

21 January 2018

Identifiers

DOI

10.1093/QJMED/93.10.689

1 reference

30 July 2017

1 reference